Global Point Of Care Diagnostics Market, 2016 – 2022
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Published By: Zion <strong>Market</strong> Research<br />
<strong>Global</strong> <strong>Point</strong> <strong>Of</strong> <strong>Care</strong> <strong>Diagnostics</strong> <strong>Market</strong> Set for Rapid<br />
Growth to Reach around USD 40.50 Billion by <strong>2022</strong><br />
Contact Us:<br />
4283, Express Lane, Suite 634-143,<br />
Sarasota, Florida 34249, United States<br />
Tel: +1-386-310-3803 GMT<br />
Tel: +49-322 210 92714<br />
USA/Canada Toll Free No.1-855-465-4651<br />
sales@zionmarketresearch.com
<strong>Point</strong> <strong>Of</strong> <strong>Care</strong> <strong>Diagnostics</strong> <strong>Market</strong><br />
Zion <strong>Market</strong> Research has published a new report titled “<strong>Point</strong> <strong>Of</strong> <strong>Care</strong> <strong>Diagnostics</strong> <strong>Market</strong><br />
by Products, by Prescription Mode (Prescription-Based Testing Kits and Over-The-<br />
Counter Testing Kits) <strong>Market</strong> for Hospitals, Clinics and Ambulatory <strong>Care</strong> Settings:<br />
<strong>Global</strong> Industry Perspective, Comprehensive Analysis, and Forecast, <strong>2016</strong> <strong>–</strong><br />
<strong>2022</strong>”. According to the report, the global point of care diagnostics market was valued at<br />
approximately USD 23.50 billion in <strong>2016</strong> and is expected to reach approximately USD 40.50<br />
billion by <strong>2022</strong>, growing at a CAGR of around 10.00% between 2017 and <strong>2022</strong>.<br />
The point of <strong>Care</strong> <strong>Diagnostics</strong> is medical testing performed at the clinical laboratory in close<br />
proximity to where the patient is receiving care. POCT is usually performed by non-laboratory<br />
persons and the results are used for clinical decision making. <strong>Point</strong>- of-care technologies may<br />
enhance the management of different diseases and conditions. The point of <strong>Care</strong> diagnostics is<br />
of great importance in developing countries. Unfortunately, a major aspect in developing<br />
countries is that they often lack modern laboratories, fully automated instruments that provide<br />
highly reproducible, quantitative, and hence sensitive and accurate diagnostic results. In order<br />
to circumvent these issues, the emergence of rapid and easy-to-use point-of-care (POC) tests<br />
can dramatically enhance a physician’s ability to diagnose patients’ diseases rapidly and<br />
accurately.
<strong>Point</strong> <strong>Of</strong> <strong>Care</strong> <strong>Diagnostics</strong> <strong>Market</strong><br />
The point of care diagnostics market is expected to witness lucrative growth in the near future.<br />
The market is mainly driven by technological advancement and cost-effective and high-quality<br />
medical solutions. Moreover, increasing prevalence of target diseases coupled with the rise in<br />
the aging population base which is more prone to disease growth are attributive to impact the<br />
POCT demand considerably over the years to come. However, the high cost of procedure and<br />
presence of stringent and time-consuming ambiguous regulatory framework are expected to<br />
hamper the market growth within the forecast period. Nonetheless, increasing demand from<br />
emerging economies and health care decentralization may open up new growth avenues in the<br />
near future.<br />
Request Free Sample copy of <strong>Global</strong> <strong>Point</strong> <strong>Of</strong> <strong>Care</strong> <strong>Diagnostics</strong> <strong>Market</strong> Report @<br />
https://www.zionmarketresearch.com/sample/point-of-care-diagnostics-market<br />
The market can be segmented on the basis of products into glucose monitoring kits, cardiometabolic<br />
monitoring kits, infectious diseases testing kits, coagulation monitoring kits,<br />
pregnancy and fertility testing kits, tumor/cancer markers, urinalysis testing kits, cholesterol<br />
test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits and<br />
others. Glucose testing held 40% share of the overall market in terms of revenue in <strong>2016</strong>.<br />
Increasing prevalence of diabetes across the globe is expected to boost the demand for glucose<br />
testing in the years to come. The infectious diseases testing kits is expected to grow at the<br />
highest CAGR during the forecast period on account of the rise in a number of HIV-infected<br />
individuals.<br />
Some of the key prescription mode present in the market such as prescription based kits and<br />
over the counter kits. Prescription-based testing kits are expected to dominate the market in the<br />
near future due to increasing incidence of lifestyle diseases and lack of awareness on over the<br />
counter POCT devices.
<strong>Point</strong> <strong>Of</strong> <strong>Care</strong> <strong>Diagnostics</strong> <strong>Market</strong><br />
Based on the end-user, the market can be segmented into hospitals, clinics, and ambulatory<br />
care settings. Clinic segment was the leading segment and it accounted for the large chunk of<br />
market share in <strong>2016</strong>. Increasing adoption of these tests in the clinics for diagnosis of several<br />
infections and monitoring of disease progression by assessment of symptoms and other<br />
parameters is expected to boost the demand for POCT in this segment. Home health care is<br />
another important segment of this segment.<br />
The global point of care market was dominated by North America with over 42% share of the<br />
total market in <strong>2016</strong>. This growth is mainly due to increased prevalence of diseases in the<br />
region and presence of favorable government regulations and initiatives pertaining to the<br />
development of healthcare infrastructure. Asia Pacific is another important regional market and<br />
is expected to show witness fastest growth in the near future. This can be attributed to the<br />
presence of high unmet medical needs and technological advancement in healthcare<br />
infrastructure, growing medical awareness, and rise in per capita income levels in developing<br />
economies of including India and China.<br />
Some of the key players in the market such as Roche <strong>Diagnostics</strong>, Alere Inc ., Danaher<br />
Corporation, Abbott Laboratories, Johnson and Johnson, Instrumentation Laboratory, Trinity<br />
Biotech PLC, OraSure Technologies Inc, bioMerieux, Qiagen N.V. and Siemens Healthcare.<br />
Browse the full “<strong>Point</strong> <strong>Of</strong> <strong>Care</strong> <strong>Diagnostics</strong> <strong>Market</strong> by Products, by Prescription Mode<br />
(Prescription-Based Testing Kits and Over-the-Counter Testing Kits) <strong>Market</strong> for<br />
Hospitals, Clinics and Ambulatory <strong>Care</strong> Settings: <strong>Global</strong> Industry Perspective,<br />
Comprehensive Analysis, and Forecast, <strong>2016</strong> <strong>–</strong> <strong>2022</strong>” report<br />
at https://www.zionmarketresearch.com/report/point-of-care-diagnostics-market
<strong>Point</strong> <strong>Of</strong> <strong>Care</strong> <strong>Diagnostics</strong> <strong>Market</strong><br />
Zion <strong>Market</strong> Research<br />
Address: 4283, Express Lane, Suite 634-143, Sarasota, Florida 34249, United States<br />
Tel: +1-386-310-3803 GMT +49-322 210 92714<br />
Tel: +1-855-465-4651 (US/CAN TOLL FREE)<br />
Email: sales@zionmarketresearch.com Web: www.zionmarketresearch.com